search
Back to results

Controlled MAP in the Brain Injury Patient (COMAT Study) (COMAT)

Primary Purpose

Brain Injuries

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
EV1000 and closed-loop system
Control group
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Brain Injuries

Eligibility Criteria

18 Years - 99 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • severe brain injury patients (Glasgow score <9), intubated, ventilated and sedated.

Exclusion Criteria:

  • Glasgow score > 8
  • Bilateral mydriasis at the initial management (Ambulance and first hour of arrival)

Sites / Locations

  • Bicêtre hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

EV1000 monitor

EV1000 monitor + closed-loop system

Arm Description

MAP management will be done as usual (adjustment by nurses) and fluid management will be managed using the EV1000 monitoring device with the automated decision support system

Fluid management will be done using the automated decision support system and MAP will be adjusted by the automated closed-loop system for vasopressor administration

Outcomes

Primary Outcome Measures

Mean arterial pressure (MAP)
percentage of treatment time when MAP will be in the predefined range (+/- 5 mmHg of the target MAP)

Secondary Outcome Measures

Percentage of case time spent in Hypotension
percentage time spent with MAP below 5 mmHg of the predefined MAP
Percentage of case time spent Hypertension
percentage time spent with MAP above 5 mmHg of the predefined MAP
Cerebral perfusion pressure
Measure of Cerebral perfusion pressure during the treatment time (evolution of Cerebral perfusion pressure over time)
Intracranial pressure
Measure of intracranial pressure during the treatment time (evolution over time)
Intracranial pressure Hypertension
percentage of intracranial pressure over 20 mmHg during the treatment period
Fluid received
comparison of amount of fluid received during the treatment period
Amount of vasopressor
amount of vasopressor received during the treatment period
Length of stay in the intensive care unit
comparison of the length of stay in the intensive care unit between both groups.
mean arterial pressure (MAP)
MAP over the treatment period
stroke volume
stroke volume over the treatment period
cardiac index
cardiac index over the treatment period. This will be the mean values over the procedure. Measurements recorded each 20 seconds and averaged for the procedure. The unit is l/min/m-2
Transcranial doppler
measure of mean cerebral velocity of mean cerebral artery

Full Information

First Posted
May 24, 2019
Last Updated
May 26, 2023
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
University of California, Los Angeles, University of California, Irvine
search

1. Study Identification

Unique Protocol Identification Number
NCT03991052
Brief Title
Controlled MAP in the Brain Injury Patient (COMAT Study)
Acronym
COMAT
Official Title
Controlled Mean Arterial Pressure of Brain Injury Patients Using an Novel Automated System for Vasopressor Administration : a Randomized Controlled Trial in Critically Ill Patients in the Intensive Care Unit
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Completed
Study Start Date
December 18, 2019 (Actual)
Primary Completion Date
July 7, 2021 (Actual)
Study Completion Date
July 7, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
University of California, Los Angeles, University of California, Irvine

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this randomized controlled trial will be to show that the use of a novel automated system to guide vasopressor administration in brain injury patients will results in more time spent with a mean arterial pressure (MAP) within the predefined MAP (+/- 5 mmHg of the target MAP) compared to patients managed without any automated system (manually management)
Detailed Description
In brain injury patients, the maintenance of MAP within a very narrow range is desired to avoid complications related to hypoperfusion (undertreatment) or hypertension (over treatment). However, the MAP needed to reach can vary over time based on intracranial pressure. Additionally, it is well know that the nurses in the Intensive care unit managed multiple patients simultaneously and cannot dedicate 100% of his-her time to adjust drugs infusions. Using a novel automated system can overcome this issue and may lead to more time in MAP target (+/- 5mmHg) than the traditional management. After initial rescuscitation of the patients, patients in both groups will have the same baseline maintenance fluid administration of 1-2 ml/kg/h of crystalloid solution and additionnal fluid boluses administered following the EV1000 monitoring device. The only difference will be the management of vasopressor titration (manual by nurses vs automated via a closed-loop system)

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Brain Injuries

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
manual versus automated management of MAP
Masking
Participant
Allocation
Randomized
Enrollment
23 (Actual)

8. Arms, Groups, and Interventions

Arm Title
EV1000 monitor
Arm Type
Active Comparator
Arm Description
MAP management will be done as usual (adjustment by nurses) and fluid management will be managed using the EV1000 monitoring device with the automated decision support system
Arm Title
EV1000 monitor + closed-loop system
Arm Type
Experimental
Arm Description
Fluid management will be done using the automated decision support system and MAP will be adjusted by the automated closed-loop system for vasopressor administration
Intervention Type
Device
Intervention Name(s)
EV1000 and closed-loop system
Intervention Description
This system will recommend when patients need fluid or not and adjust vasopressor administration automatically by the closed-loop system
Intervention Type
Device
Intervention Name(s)
Control group
Intervention Description
This system will recommend when patients need fluid or not and nurses will adjust vasopressor administration as usual (standard of care)
Primary Outcome Measure Information:
Title
Mean arterial pressure (MAP)
Description
percentage of treatment time when MAP will be in the predefined range (+/- 5 mmHg of the target MAP)
Time Frame
48 hours post-admission in the intensive care unit
Secondary Outcome Measure Information:
Title
Percentage of case time spent in Hypotension
Description
percentage time spent with MAP below 5 mmHg of the predefined MAP
Time Frame
48 hours post-admission in the intensive care unit
Title
Percentage of case time spent Hypertension
Description
percentage time spent with MAP above 5 mmHg of the predefined MAP
Time Frame
48 hours post-admission in the intensive care unit
Title
Cerebral perfusion pressure
Description
Measure of Cerebral perfusion pressure during the treatment time (evolution of Cerebral perfusion pressure over time)
Time Frame
48 hours post-admission in the intensive care unit
Title
Intracranial pressure
Description
Measure of intracranial pressure during the treatment time (evolution over time)
Time Frame
48 hours post-admission in the intensive care unit
Title
Intracranial pressure Hypertension
Description
percentage of intracranial pressure over 20 mmHg during the treatment period
Time Frame
48 hours post-admission in the intensive care unit
Title
Fluid received
Description
comparison of amount of fluid received during the treatment period
Time Frame
48 hours post-admission in the intensive care unit
Title
Amount of vasopressor
Description
amount of vasopressor received during the treatment period
Time Frame
48 hours post-admission in the intensive care unit
Title
Length of stay in the intensive care unit
Description
comparison of the length of stay in the intensive care unit between both groups.
Time Frame
30 days post-admission in the intensive care unit
Title
mean arterial pressure (MAP)
Description
MAP over the treatment period
Time Frame
48 hours post-admission in the intensive care unit
Title
stroke volume
Description
stroke volume over the treatment period
Time Frame
48 hours post-admission in the intensive care unit
Title
cardiac index
Description
cardiac index over the treatment period. This will be the mean values over the procedure. Measurements recorded each 20 seconds and averaged for the procedure. The unit is l/min/m-2
Time Frame
48 hours post-admission in the intensive care unit
Title
Transcranial doppler
Description
measure of mean cerebral velocity of mean cerebral artery
Time Frame
48 hours post-admission in the intensive care unit

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: severe brain injury patients (Glasgow score <9), intubated, ventilated and sedated. Exclusion Criteria: Glasgow score > 8 Bilateral mydriasis at the initial management (Ambulance and first hour of arrival)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jacques DURANTEAU, MD, PhD
Organizational Affiliation
Bicetre
Official's Role
Study Chair
Facility Information:
Facility Name
Bicêtre hospital
City
Le Kremlin-Bicêtre
ZIP/Postal Code
94270
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Controlled MAP in the Brain Injury Patient (COMAT Study)

We'll reach out to this number within 24 hrs